GenomeWeb/Mizuho Survey Finds Researchers Optimistic for Sequencing Funding, Market Growth | GenomeWeb

The genomics research community is optimistic that sequencing will continue to see an increase in research funding over the next 12 months, according to a survey conducted by GenomeWeb in collaboration with Mizuho Securities.

The survey also found that respondents expect sequencing to overtake microarrays in most applications within five years, that they believe sequencing will penetrate the consumer market within approximately six years, and that the average price point at which most respondents would get their genome sequenced is $700.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: a global genetic interaction map for Saccharomyces cerevisiae, and progress made in genomics, precision medicine, and therapeutics.

The price of plane tickets can affect how scientists in different countries choose to collaborate with each other, NPR reports.

The Annals of Improbable Research has awarded the 2016 Ig Nobel Prizes.

Scientific American alleges that the FDA has been "arm-twisting journalists into relinquishing their reportorial independence."